Corporate News     10-Apr-17
Marksans Pharma intimates of USFDA inspection of its manufacturing facility at Goa
Receives 4 observations under Form 483
Marksans Pharma announced that the United States Food & Drug Administration inspected its manufacturing facility located at Goa from 03 April to 07 April 2017. At the end of the inspections, there were 4 (four) observations given under Form 483. The company is already addressing the same and is confident of satisfying the FDA within stipulated time.
Previous News
  Marksans Pharma standalone net profit declines 33.55% in the June 2022 quarter
 ( Results - Announcements 14-Aug-22   14:23 )
  Marksans Pharma to conduct AGM
 ( Corporate News - 01-Aug-22   16:48 )
  Marksans Pharma to conduct board meeting
 ( Corporate News - 11-Jan-23   15:37 )
  Marksans arm receives UK MHRA marketing authorisation for Cyanocobalamin 50mg film coated tablet
 ( Corporate News - 06-Nov-23   18:30 )
  Marksans Pharma consolidated net profit rises 333.91% in the March 2020 quarter
 ( Results - Announcements 02-Jun-20   12:02 )
  Marksans Pharma Ltd Slips 4.87%
 ( Hot Pursuit - 08-Jun-20   09:45 )
  Marksans Pharma to convene board meeting
 ( Corporate News - 04-Aug-23   14:03 )
  Morepen Laboratories Ltd leads gainers in 'A' group
 ( Hot Pursuit - 30-Jun-22   12:00 )
  Marksans Pharma subsidiary recalls drugs for packaging issue
 ( Corporate News - 21-Jun-22   12:11 )
  Marksans Pharma jumps after subsidiary receives market authorization for diarrhoea drug
 ( Hot Pursuit - 10-Dec-21   09:17 )
  Marksans Pharma consolidated net profit declines 9.65% in the June 2019 quarter
 ( Results - Announcements 10-Aug-19   11:37 )
Other Stories
  Share India Securities allots 16.92 lakh equity shares on conversion of warrants
  06-Jul-24   13:11
  Tinna Trade raises Rs 49 cr to fund its growth plans
  06-Jul-24   11:10
  Integra Essentia announces merger with G G Engineering
  06-Jul-24   11:05
  Ugro Capital to raise Rs 75 cr via NCD issuance
  06-Jul-24   10:58
  Board of D.P. Abhushan approves preferential allotment of shares and warrants
  06-Jul-24   10:50
  Life Insurance Corporation of India invest Rs 14 cr in Sri Lankan subsidiary
  06-Jul-24   10:49
  High Energy Batteries (India) to discuss results
  06-Jul-24   10:29
  Havells India schedules board meeting
  06-Jul-24   10:29
  Axis Bank announces board meeting date
  06-Jul-24   10:29
  Mastek to conduct board meeting
  06-Jul-24   10:29
Back Top